Case study · Global pharma · Market access, APAC

A scalable knowledge base — evidence on demand

Global dossiers, local data, clinical and real-world evidence, and literature all lived in separate places. Every market request restarted the assembly work, and no two versions agreed.

01 · Global pharma · Market access, APAC

One base, generated market by market

One governed knowledge base unifies global and local evidence. Dossiers and value stories are generated from it market by market, rather than rebuilt each time.

Evidence in Governed base Evidence out
The bottleneck

Global dossiers, local data, clinical and real-world evidence, and literature all lived in separate places. Every market request restarted the assembly work, and no two versions agreed.

What we built
  • A regional value dossier for Asia and the global dossier localised
  • Six plus two local value stories generated from the same base
  • A continuous systematic literature review layer
  • Provenance tracking on every claim, updated in place
Outcome

Reused across 8 APAC markets from a single source of truth. For this workflow, creation moved from weeks and months to days, with every claim traceable for MLR review.

Now reusable

systematic_lit_review · dossier_assembly · localisation · reference_linking · heor_agent — all carried into later engagements.

This is the same pattern the Market access & HEOR page describes: one governed evidence base instead of a per-market rebuild. If your team's HTA pipeline looks like this, that page has the fuller breakdown of what runs underneath it.

See the Market access & HEOR solution →

See the other three deployments.

Client names, references, and full results available under NDA.

All case studies
ECLYPSE AI

Our proprietary AI orchestration platform for healthcare: one engine, a registry of reusable task modules and domain agents, and a governed knowledge base — deployed inside your walls and run by your team.

© 2026 Eclypse Pte. Ltd. Privacy policy
Singapore